Editorial Correspondence
Medicine Sermorelin publishes summaries of the peer-reviewed Sermorelin and GHRH (1-29) research literature. We welcome editorial correspondence on the published record — corrections of factual errors, suggestions of additional primary sources we should incorporate, or questions about specific citations we have summarized. Use the contact form below.
What we cannot respond to: clinical questions, dosing requests, prescription inquiries, sourcing or vendor questions, telehealth referrals, or requests for medical advice. Those requests will not receive a reply. Medicine Sermorelin is an editorial project — not a clinic, not a pharmacy, not a telehealth service — and the staff that maintains the site is not qualified to answer clinical questions about Sermorelin or any other compound.
We particularly welcome correspondence from researchers who have identified primary sources we have overlooked, from readers who have found errors in our summaries of cited studies, and from clinicians or pharmacologists who can clarify points of mechanism, pharmacokinetics, or comparative pharmacology that this site has summarized imprecisely. The Sermorelin literature is bounded but not small, and any editorial digest of it benefits from outside reading.
Contact Form
The form below collects your name, your email address, and your message. We use the information you submit only to respond to your message; we do not add you to any mailing list and we do not share submissions with any third party. Please indicate in your message which page of the site your correspondence concerns and, where relevant, which citation number you are referring to.
For citation queries: please include the citation number (e.g., '05'), the page on which it appears, and the specific quantitative claim or wording in question. For corrections: please cite the primary source supporting the correction. For source suggestions: please include the DOI, PubMed ID, or full citation of the source you believe should be incorporated. The form will not auto-respond and will not be used for any marketing purpose; a human reads each submission.
Editorial Independence Note
Medicine Sermorelin has no commercial relationship with any Sermorelin manufacturer, compounding pharmacy, telehealth service, or clinical service. We do not accept payment for editorial coverage of any specific product or formulation. We do not run paid advertising for Sermorelin or any related peptide. Our editorial work is funded by the project's owner and is independent of any product or service the published literature discusses.
Privacy Note
The information you submit through the contact form is used only to respond to your message. We do not store your email address in any mailing list, we do not share submissions with any third party, and we do not retain submissions beyond the period necessary to respond. We do not use cookies to track form submissions. The site overall uses minimal first-party analytics for traffic counting; we do not run third-party advertising trackers, retargeting pixels, or social-media trackers across the site.
For formal correspondence regarding the editorial record — corrections, source citations, factual disputes — please use the contact form with a clear subject line indicating the page and citation in question. We will respond to substantive editorial correspondence within a reasonable interval. For clinical, dosing, sourcing, or vendor questions, please consult an appropriate qualified professional; this editorial project is not equipped to provide that guidance and will not attempt to.
Medicine Sermorelin is part of an editorial project run by an independent publisher. The site is operated as an editorial digest of the peer-reviewed Sermorelin and GHRH (1-29) research literature; it is not affiliated with any pharmaceutical company, compounding pharmacy, research institution, telehealth service, or clinical practice. Editorial inquiries and source suggestions are welcome through the contact form. Clinical inquiries are not. For matters of editorial fact concerning Sermorelin pharmacology or clinical-trial citation, we will adjust the published page and credit the correction on the relevant references entry where appropriate.